Sunny Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SUNNY
SUNNY has seven approved drugs.
Drugs and US Patents for Sunny
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sunny | CYCLOPHOSPHAMIDE | cyclophosphamide | INJECTABLE;INJECTION | 215089-002 | Oct 26, 2023 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sunny | AMINOCAPROIC ACID | aminocaproic acid | TABLET;ORAL | 209060-001 | Nov 27, 2018 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sunny | CHLORTHALIDONE | chlorthalidone | TABLET;ORAL | 209068-002 | Jan 25, 2022 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Sunny | CARBOPROST TROMETHAMINE | carboprost tromethamine | INJECTABLE;INJECTION | 213118-001 | Mar 25, 2021 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sunny | CYCLOPHOSPHAMIDE | cyclophosphamide | INJECTABLE;INJECTION | 215089-001 | Oct 26, 2023 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sunny | CYCLOPHOSPHAMIDE | cyclophosphamide | INJECTABLE;INJECTION | 215089-003 | Oct 26, 2023 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sunny | AMINOCAPROIC ACID | aminocaproic acid | TABLET;ORAL | 209060-002 | Nov 27, 2018 | AB | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

